PortfoliosLab logo
DDS vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DDS and NVO is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

DDS vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

0.00%20,000.00%40,000.00%60,000.00%80,000.00%NovemberDecember2025FebruaryMarchApril
2,620.85%
44,755.49%
DDS
NVO

Key characteristics

Sharpe Ratio

DDS:

-0.46

NVO:

-1.22

Sortino Ratio

DDS:

-0.41

NVO:

-1.85

Omega Ratio

DDS:

0.95

NVO:

0.76

Calmar Ratio

DDS:

-0.47

NVO:

-0.85

Martin Ratio

DDS:

-1.10

NVO:

-1.70

Ulcer Index

DDS:

18.01%

NVO:

29.80%

Daily Std Dev

DDS:

43.14%

NVO:

41.57%

Max Drawdown

DDS:

-93.94%

NVO:

-71.29%

Current Drawdown

DDS:

-33.98%

NVO:

-56.90%

Fundamentals

Market Cap

DDS:

$5.17B

NVO:

$276.17B

EPS

DDS:

$36.82

NVO:

$3.43

PE Ratio

DDS:

9.12

NVO:

18.10

PEG Ratio

DDS:

-1.28

NVO:

0.92

PS Ratio

DDS:

0.78

NVO:

0.95

PB Ratio

DDS:

2.93

NVO:

12.66

Total Revenue (TTM)

DDS:

$6.57B

NVO:

$225.05B

Gross Profit (TTM)

DDS:

$2.56B

NVO:

$190.45B

EBITDA (TTM)

DDS:

$948.26M

NVO:

$113.24B

Returns By Period

In the year-to-date period, DDS achieves a -22.20% return, which is significantly higher than NVO's -26.67% return. Over the past 10 years, DDS has outperformed NVO with an annualized return of 12.68%, while NVO has yielded a comparatively lower 10.46% annualized return.


DDS

YTD

-22.20%

1M

-6.39%

6M

-6.18%

1Y

-20.68%

5Y*

68.65%

10Y*

12.68%

NVO

YTD

-26.67%

1M

-8.97%

6M

-44.36%

1Y

-50.09%

5Y*

15.92%

10Y*

10.46%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DDS vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DDS
The Risk-Adjusted Performance Rank of DDS is 2525
Overall Rank
The Sharpe Ratio Rank of DDS is 2626
Sharpe Ratio Rank
The Sortino Ratio Rank of DDS is 2626
Sortino Ratio Rank
The Omega Ratio Rank of DDS is 2727
Omega Ratio Rank
The Calmar Ratio Rank of DDS is 2222
Calmar Ratio Rank
The Martin Ratio Rank of DDS is 2424
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 33
Overall Rank
The Sharpe Ratio Rank of NVO is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 33
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 44
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 44
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DDS vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for DDS, currently valued at -0.46, compared to the broader market-2.00-1.000.001.002.003.00
DDS: -0.46
NVO: -1.22
The chart of Sortino ratio for DDS, currently valued at -0.41, compared to the broader market-6.00-4.00-2.000.002.004.00
DDS: -0.41
NVO: -1.85
The chart of Omega ratio for DDS, currently valued at 0.95, compared to the broader market0.501.001.502.00
DDS: 0.95
NVO: 0.76
The chart of Calmar ratio for DDS, currently valued at -0.47, compared to the broader market0.001.002.003.004.005.00
DDS: -0.47
NVO: -0.85
The chart of Martin ratio for DDS, currently valued at -1.10, compared to the broader market-5.000.005.0010.0015.0020.00
DDS: -1.10
NVO: -1.70

The current DDS Sharpe Ratio is -0.46, which is higher than the NVO Sharpe Ratio of -1.22. The chart below compares the historical Sharpe Ratios of DDS and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-0.46
-1.22
DDS
NVO

Dividends

DDS vs. NVO - Dividend Comparison

DDS's dividend yield for the trailing twelve months is around 7.75%, more than NVO's 2.60% yield.


TTM20242023202220212020201920182017201620152014
DDS
Dillard's, Inc.
7.75%6.02%5.18%4.89%6.41%0.95%0.68%0.66%0.57%0.45%0.40%0.19%
NVO
Novo Nordisk A/S
2.60%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%

Drawdowns

DDS vs. NVO - Drawdown Comparison

The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.29%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-33.98%
-56.90%
DDS
NVO

Volatility

DDS vs. NVO - Volatility Comparison

Dillard's, Inc. (DDS) has a higher volatility of 19.24% compared to Novo Nordisk A/S (NVO) at 16.79%. This indicates that DDS's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
19.24%
16.79%
DDS
NVO

Financials

DDS vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items